Redemplo (plozasiran) - Arrowhead
Arrowhead Pharmaceuticals to Participate in Upcoming December 2025 Conferences (Businesswire) - Dec 2, 2025 - "Arrowhead Pharmaceuticals, Inc...announced that it is scheduled to participate in the following upcoming events: Piper Sandler 37th Annual Healthcare Conference – December 2-4, 2025; 8th Annual Evercore Healthcare Conference – December 2-4, 2025; World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) – December 4-6, 2025." 
Clinical data Familial Chylomicronemia Syndrome • Pancreatitis • Severe Hypertriglyceridemia
https://www.businesswire.com/news/home/20251201268006/en/Arrowhead-Pharmaceuticals-to-Participate-in-Upcoming-December-2025-Conferences
 
Dec 2, 2025